Abstract
The myc gene was initially discovered as a prototypical retrovirally transduced oncogene. Over the decades, abundant evidence has emerged to support a causal role for the activated cellular gene, c-myc, in animal and human tumors. The gene encodes an oncogenic helix-loop-helix leucine zipper transcription factor that acts as a heterodimer with its partner protein, Max, to activate genes regulating the cell cycle machinery as well as critical metabolic enzymes. The additional ability of c-Myc to repress transcription of differentiation-related genes suggest that c-Myc is a central and key molecular integrator of cell proliferation, differentiation and metabolism.
Original language | English (US) |
---|---|
Pages (from-to) | 269-278 |
Number of pages | 10 |
Journal | Journal of Biomedical Science |
Volume | 4 |
Issue number | 6 |
DOIs | |
State | Published - 1997 |
Keywords
- Apoptosis
- C-Myc
- Cancer
- Metabolism
- Oncogene
- Transcription
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)